Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCT

L. Castagna, R. Boubdallah, S. Furst, D. Coso, J. El Cheikh, C. Faucher, R. Crocchiolo, A. Granata, C. Chabannon, C. Lemarié, B. Calmels, J. M. Boher, M. Mothy, D. Blaise

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

We analyzed 113 patients with lymphoma who underwent allogeneic transplantation with reduced-intensity conditioning (allo-RIC) regimens at a single institution, from February 2001 through November 2009, searching for factors predictive of the outcome. At the time of transplantation, 60% of patients were in CR, 29% in PR and 11% had progressive or stable disease. At a median follow-up of 34 months (confidence interval (CI) 17-45), the 3-year OS and PFS were 59% (CI 48-68%) and 51% (CI 41-61%), respectively. The 100-day and 2-year nonrelapse mortalities (NRM) were 6% and 28% (CI 20-35%), respectively. Grade II-IV acute GVHD (aGVHD) incidence was 38%, and the global incidence of chronic GVHD was 33%. In univariate analysis, OS was influenced by disease status before allo-RIC; aGVHD negatively affected on survival. Similarly, PFS was influenced only by disease status. Histological subtype did not affect OS or PFS. We conclude that disease status at the time of transplantation significantly influences survival in patients receiving allo-RIC for lymphoma, whereas histological subtype does not. This reinforces the need to administer more effective debulking treatments to lymphoma patients, for optimal benefit of allogeneic immune recognition of minimal residual disease, independently from lymphoma histology.

Original languageEnglish
Pages (from-to)794-798
Number of pages5
JournalBone Marrow Transplantation
Volume48
Issue number6
DOIs
Publication statusPublished - Jun 2013

Fingerprint

Lymphoma
Homologous Transplantation
Histology
Confidence Intervals
Transplantation
Survival
Incidence
Residual Neoplasm
Mortality
Therapeutics

Keywords

  • allogeneic
  • lymphomas
  • reduced-intensity conditioning regimen

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCT. / Castagna, L.; Boubdallah, R.; Furst, S.; Coso, D.; El Cheikh, J.; Faucher, C.; Crocchiolo, R.; Granata, A.; Chabannon, C.; Lemarié, C.; Calmels, B.; Boher, J. M.; Mothy, M.; Blaise, D.

In: Bone Marrow Transplantation, Vol. 48, No. 6, 06.2013, p. 794-798.

Research output: Contribution to journalArticle

Castagna, L, Boubdallah, R, Furst, S, Coso, D, El Cheikh, J, Faucher, C, Crocchiolo, R, Granata, A, Chabannon, C, Lemarié, C, Calmels, B, Boher, JM, Mothy, M & Blaise, D 2013, 'Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCT', Bone Marrow Transplantation, vol. 48, no. 6, pp. 794-798. https://doi.org/10.1038/bmt.2012.225
Castagna, L. ; Boubdallah, R. ; Furst, S. ; Coso, D. ; El Cheikh, J. ; Faucher, C. ; Crocchiolo, R. ; Granata, A. ; Chabannon, C. ; Lemarié, C. ; Calmels, B. ; Boher, J. M. ; Mothy, M. ; Blaise, D. / Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCT. In: Bone Marrow Transplantation. 2013 ; Vol. 48, No. 6. pp. 794-798.
@article{3f64ba60402b4dfa8b332324cf96ed10,
title = "Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCT",
abstract = "We analyzed 113 patients with lymphoma who underwent allogeneic transplantation with reduced-intensity conditioning (allo-RIC) regimens at a single institution, from February 2001 through November 2009, searching for factors predictive of the outcome. At the time of transplantation, 60{\%} of patients were in CR, 29{\%} in PR and 11{\%} had progressive or stable disease. At a median follow-up of 34 months (confidence interval (CI) 17-45), the 3-year OS and PFS were 59{\%} (CI 48-68{\%}) and 51{\%} (CI 41-61{\%}), respectively. The 100-day and 2-year nonrelapse mortalities (NRM) were 6{\%} and 28{\%} (CI 20-35{\%}), respectively. Grade II-IV acute GVHD (aGVHD) incidence was 38{\%}, and the global incidence of chronic GVHD was 33{\%}. In univariate analysis, OS was influenced by disease status before allo-RIC; aGVHD negatively affected on survival. Similarly, PFS was influenced only by disease status. Histological subtype did not affect OS or PFS. We conclude that disease status at the time of transplantation significantly influences survival in patients receiving allo-RIC for lymphoma, whereas histological subtype does not. This reinforces the need to administer more effective debulking treatments to lymphoma patients, for optimal benefit of allogeneic immune recognition of minimal residual disease, independently from lymphoma histology.",
keywords = "allogeneic, lymphomas, reduced-intensity conditioning regimen",
author = "L. Castagna and R. Boubdallah and S. Furst and D. Coso and {El Cheikh}, J. and C. Faucher and R. Crocchiolo and A. Granata and C. Chabannon and C. Lemari{\'e} and B. Calmels and Boher, {J. M.} and M. Mothy and D. Blaise",
year = "2013",
month = "6",
doi = "10.1038/bmt.2012.225",
language = "English",
volume = "48",
pages = "794--798",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCT

AU - Castagna, L.

AU - Boubdallah, R.

AU - Furst, S.

AU - Coso, D.

AU - El Cheikh, J.

AU - Faucher, C.

AU - Crocchiolo, R.

AU - Granata, A.

AU - Chabannon, C.

AU - Lemarié, C.

AU - Calmels, B.

AU - Boher, J. M.

AU - Mothy, M.

AU - Blaise, D.

PY - 2013/6

Y1 - 2013/6

N2 - We analyzed 113 patients with lymphoma who underwent allogeneic transplantation with reduced-intensity conditioning (allo-RIC) regimens at a single institution, from February 2001 through November 2009, searching for factors predictive of the outcome. At the time of transplantation, 60% of patients were in CR, 29% in PR and 11% had progressive or stable disease. At a median follow-up of 34 months (confidence interval (CI) 17-45), the 3-year OS and PFS were 59% (CI 48-68%) and 51% (CI 41-61%), respectively. The 100-day and 2-year nonrelapse mortalities (NRM) were 6% and 28% (CI 20-35%), respectively. Grade II-IV acute GVHD (aGVHD) incidence was 38%, and the global incidence of chronic GVHD was 33%. In univariate analysis, OS was influenced by disease status before allo-RIC; aGVHD negatively affected on survival. Similarly, PFS was influenced only by disease status. Histological subtype did not affect OS or PFS. We conclude that disease status at the time of transplantation significantly influences survival in patients receiving allo-RIC for lymphoma, whereas histological subtype does not. This reinforces the need to administer more effective debulking treatments to lymphoma patients, for optimal benefit of allogeneic immune recognition of minimal residual disease, independently from lymphoma histology.

AB - We analyzed 113 patients with lymphoma who underwent allogeneic transplantation with reduced-intensity conditioning (allo-RIC) regimens at a single institution, from February 2001 through November 2009, searching for factors predictive of the outcome. At the time of transplantation, 60% of patients were in CR, 29% in PR and 11% had progressive or stable disease. At a median follow-up of 34 months (confidence interval (CI) 17-45), the 3-year OS and PFS were 59% (CI 48-68%) and 51% (CI 41-61%), respectively. The 100-day and 2-year nonrelapse mortalities (NRM) were 6% and 28% (CI 20-35%), respectively. Grade II-IV acute GVHD (aGVHD) incidence was 38%, and the global incidence of chronic GVHD was 33%. In univariate analysis, OS was influenced by disease status before allo-RIC; aGVHD negatively affected on survival. Similarly, PFS was influenced only by disease status. Histological subtype did not affect OS or PFS. We conclude that disease status at the time of transplantation significantly influences survival in patients receiving allo-RIC for lymphoma, whereas histological subtype does not. This reinforces the need to administer more effective debulking treatments to lymphoma patients, for optimal benefit of allogeneic immune recognition of minimal residual disease, independently from lymphoma histology.

KW - allogeneic

KW - lymphomas

KW - reduced-intensity conditioning regimen

UR - http://www.scopus.com/inward/record.url?scp=84879093629&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879093629&partnerID=8YFLogxK

U2 - 10.1038/bmt.2012.225

DO - 10.1038/bmt.2012.225

M3 - Article

C2 - 23222387

AN - SCOPUS:84879093629

VL - 48

SP - 794

EP - 798

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 6

ER -